| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Medpace Holdings, Inc. (MEDP) have been net sellers, shedding 23,587 shares worth roughly $11.7M on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. MEDP sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 638.9K | $382.39M | -7,238 | |
| VP | 47.5K | $28.43M | - | |
| Other | 20.3K | $12.17M | - | |
| Pres | 15.0K | $8.98M | - | |
| CFO | 5.8K | $3.49M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Medpace Investors, LLC69 | 10% Owner | Sell | 100,000 | $400.25 | $40,024,600.00 | -1.0% | -4.6% | -19.0% | |
| Mar 1, 2024 | Troendle August J.70 | CEO | Sell | 100,000 | $400.25 | $40,024,600.00 | -1.0% | -4.6% | -19.0% | |
| Mar 1, 2024 | Ewald Stephen P58 | General Counsel &Corp. Secy. | Sell | 1,513 | $395.19 | $597,922.82 | -5.3% | -4.6% | -19.0% | |
| Feb 29, 2024 | Geiger Jesse J57 | President | Sell | 2,558 | $393.51 | $1,006,585.79 | -40.1% | -2.4% | -17.7% | |
| Feb 28, 2024 | Keating Ashley M.67 | Director | Sale+OE | 500 | $405.00 | $202,500.00 | -100% | -3.1% | -19.1% | |
| Feb 28, 2024 | Troendle August J.70 | CEO | Sell | 100,000 | $403.01 | $40,300,500.00 | -1.0% | -3.1% | -19.1% | |
| Feb 28, 2024 | Medpace Investors, LLC69 | 10% Owner | Sell | 100,000 | $403.01 | $40,300,500.00 | -1.0% | -3.1% | -19.1% | |
| Feb 26, 2024 | Keating Ashley M.67 | Director | Sale+OE | 500 | $404.29 | $202,146.64 | -66.3% | -3.1% | -15.5% | |
| Feb 26, 2024 | Medpace Investors, LLC69 | 10% Owner | Sell | 156,928 | $401.07 | $62,938,688.64 | -1.5% | -3.1% | -15.5% | |
| Feb 26, 2024 | Troendle August J.70 | CEO | Sell | 156,928 | $401.07 | $62,938,688.64 | -1.5% | -3.1% | -15.5% |